Journal
FEBS LETTERS
Volume 586, Issue 14, Pages 1993-2002Publisher
WILEY
DOI: 10.1016/j.febslet.2012.04.030
Keywords
BMP signaling; Cardiovascular disease; Pulmonary arterial hypertension; Hereditary hemorrhagic telangiectasia; Vascular calcification; Tumor angiogenesis
Funding
- LeDucq foundation
- Netherlands Organization for Scientific Research
- Centre for Biomedical Genetics
- KNAW
- 'Innovative Medizinische Forschung' (IMF)
Ask authors/readers for more resources
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta (TGF-beta) family that signal via type I and type II serine/threonine kinase receptors and intracellular Smad transcription factors. BMPs are multifunctional regulators of development and tissue homeostasis and they were initially characterized as inducers of bone regeneration. Genetic studies in humans and mice showed that perturbations in BMP signaling lead to various diseases, such as skeletal diseases, vascular diseases and cancer. Mutations in BMP type II receptor and BMP type I receptor/activin receptor-like kinase 1 have been linked to pulmonary arterial hypertension and hereditary hemorrhagic telangiectasia, respectively. BMPs have also been implicated in promoting vascular calcification and tumor angiogenesis. In this review we discuss the role of BMP signaling in vascular diseases and the value of BMP signaling as a vascular disease marker or a therapeutic target. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available